More research is needed to confirm the effects of compounded semaglutide with B12 for weight loss
Other adverse events included increased lipase levels (mean of 6.5%), headaches (mean prevalence of 7.92%), decreased appetite (reported consistently at 7%), influenza symptoms (mean prevalence of 5.23%), dyspepsia (mean prevalence of 5.18%), and constipation (mean prevalence of 6.91%)
Nutrition recommendations for patients on weight loss drugs [Masters capstone project, Nova Southeastern University
Haines noted that it is still unclear which patients are most likely to lose muscle and how this muscle loss might impact blood sugar control
If you follow the symbol to the fine print you learn that they define this as [items in brackets are added by me and not part of the original research text] allodynia [extreme sensitivity to touch], burning sensation, dysaesthesia [disruption to sense of touch unusual, unpleasant or painful sensations], hyperaesthesia [sensations felt very intensely], pain of skin, paraesthesia [tingling, numbness or pins and needles], sensitive skin, skin burning sensation, skin discomfort, and skin sensitisation